Nishka Research was proud to participate in the 74th Indian Pharmaceutical Congress (IPC) 2025, held in Bengaluru, one of the most significant global gatherings of the pharmaceutical and life sciences community. The event brought together industry leaders, regulators, researchers, and solution providers to discuss innovation, quality, and the future of pharmaceuticals.

At Stall D15, Nishka Research showcased its specialized solutions in visual inspection kits, particle characterization, and inspection training, attracting strong interest from professionals across pharmaceutical manufacturing, quality assurance, and regulatory functions.

Live Demonstrations and Meaningful Conversations

Throughout the congress, the Nishka Research team engaged with visitors through live visual inspection challenges, practical demonstrations, and in-depth discussions. Our KNAPP kits for visual inspection training drew particular attention, as attendees experienced firsthand how subtle defects—often missed during routine inspections—can impact product quality and audit outcomes.

The live interactions sparked insightful conversations around real-world inspection challenges, compliance expectations, and the importance of structured training in meeting global regulatory standards.

Strengthening Industry Connections

IPC 2025 provided an excellent platform to connect with pharmaceutical manufacturers, quality leaders, academicians, and industry experts. The Nishka Research booth witnessed productive meetings focused on improving inspection accuracy, reducing human error, and strengthening quality systems through effective training and characterization tools.

These interactions reinforced the industry’s growing emphasis on patient safety, regulatory readiness, and continuous improvement—values that strongly align with Nishka Research’s mission.

Commitment to Quality and Innovation

Participation in the 74th IPC reaffirmed Nishka Research’s commitment to supporting the pharmaceutical industry with practical, science-backed solutions. From visual inspection kits designed for realistic training scenarios to expertise in particle characterization, our offerings continue to address critical quality challenges faced by the industry.

We thank all the visitors, partners, and industry colleagues who took the time to engage with us at IPC 2025. The conversations, feedback, and shared insights will continue to guide our efforts in delivering solutions that truly make a difference.

We look forward to building on these connections and continuing our journey toward advancing pharmaceutical quality and compliance.